We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgical Hypothermia Affects Even Warmed Patients

By HospiMedica International staff writers
Posted on 24 Jun 2014
Despite forced-air warming, hypothermia is common and often prolonged in patients undergoing non-cardiac surgery, according to a new study.

Researchers at the Cleveland Clinic (CC; OH, USA) extracted data from the most recent visit of 143,157 patients who underwent non-cardiac inpatient surgery between April 1, 2005, and February 15, 2013. More...
Patient records were only included if the anesthetic lasted at least one hour, forced-air warming was used, and time-weighted measurement of core temperature was taken in the esophagus. Estimates were obtained for one-degree temperature bands ranging from 34 °C to 37 °C.

The results showed that approximately one-third of the patients had a core temperature of 34 °C or lower for at least one hour; 8% were below 34 °C for more than three hours. The researcher found that esophageal temperatures below 35 °C as manifest in 5% of the patients significantly increased hospital length of stay and transfusion requirements, with the incidence of hypothermia greatest one hour after induction, and then progressively improving. The study was published online in the May 2014 issue of Clinical Anesthesiology.

“Hypothermia-related complications depend more on time-weighted core temperature than final intraoperative temperature. Even with forced-air warming, our results indicate that a fair fraction of patients still become hypothermic,” said lead author Prof. Daniel Sessler, MD. “In fact, almost 10% of patients were distinctly hypothermic and remained near 35 °C at the end of surgery. This is a degree of hypothermia that has been shown to cause major complications in randomized trials.”

Approximately 72,000 surgical patients around the world are warmed each day using forced-air warming convection and radiation to transfer heat from the movement of warm air across the surface of the patient’s skin. For more than 20 years, forced-air warming has been regarded as the standard of care to help prevent surgical site infections (SSIs) and other serious complications of unintended hypothermia, including increased blood loss, morbid myocardial events, and reduced resistance to surgical wound infections.

Related Links:

Cleveland Clinic



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.